The Jerusalem PostOdds rise of Trump-Kim meeting on APEC sidelines, analysts sayInquirer6 hurt after truck crashes into warehouse in Benguet townPunchObasa celebrates son’s LG chairman of the year awardDaily MaverickSomaliland briefly detains Americans accused of threatening national securityInquirer EntertainmentBINI, SB19 celebrate historic Grammy nominationsESPN CricinfoMS Dhoni ends IPL career, joins CSK as mentorZDF heuteAktuelle Pressemitteilungen des ZDFObservador DesportoPrisão preventiva para jovem suspeita de matar senhorio20 Minuten«Dauert noch»: Lena Meyer-Landrut meldet sich nach FunkstilleKhaosod EnglishThailand plans 100,000-seat stadium in Chonburi sports complexAntara NewsIndonesia aims to boost community businesses through social forestryPremium TimesPlateau records 5,457 suspected diabetes cases in nine months
The Daily Newsstand · Free, Always
Tuesday, November 17, 2026

AEON Biopharma GAAP EPS of $0.01 beats by $0.09

Translate
  • AEON Biopharma press release (AEON): Q3 GAAP EPS of $0.01 beats by $0.09.
  • The Company reported cash and cash equivalents of $11.4 million as of September 30, 2026, which does not include approximately $6.2 million of proceeds from the exercise of milestone warrants received
View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.